U.S. Peripheral Vascular Angiography Contrast Media Market To Reach $331.81 Million By 2030

U.S. Peripheral Vascular Angiography Contrast Media Market Growth & Trends

The U.S. peripheral vascular angiography contrast media market size is anticipated to reach USD 331.81 million by 2030 expanding at a CAGR of 6.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of vascular diseases, particularly among the aging population and individuals with lifestyle-associated conditions such as diabetes, hypertension, and obesity, is driving demand for advanced diagnostic imaging. Peripheral vascular angiography procedures, which utilize contrast agents to enhance the visibility of blood vessels, are essential for the early detection and accurate diagnosis of peripheral artery disease and other circulatory disorders.

Lifestyle-associated diseases, such as diabetes, obesity, hypertension, and smoking, are becoming more common worldwide. These conditions significantly increase the risk of developing peripheral vascular diseases. For instance, diabetes and hypertension can damage blood vessels, leading to a higher likelihood of vascular complications. As the number of individuals living with these lifestyle-related conditions continues to grow globally, there is an associated rise in the demand for diagnostic imaging. Peripheral vascular angiography, which utilizes contrast media to provide clear and detailed images of the blood vessels, is crucial in diagnosing these conditions and enabling timely medical interventions. This increasing prevalence of lifestyle-related disorders directly drives the demand for angiography contrast media. According to Yeditepe University Hospital, by 2025, hypertension patients are expected to reach 1.5 billion. 1 in 3 people over the age of 60 have hypertension.

However, one of the major factors restraining the growth of the market is the high cost of diagnostic imaging procedures, particularly angiography. Advanced imaging technologies, such as those used in peripheral vascular angiography, require expensive equipment, skilled personnel, and specialized contrast media. This high cost can limit access to these procedures, particularly in regions with lower healthcare budgets, and may deter some patients or healthcare providers from opting for diagnostic angiography. Moreover, patients without adequate insurance coverage may face out-of-pocket costs, reducing the overall demand for these services.

 Request a free sample copy or view report summary: U.S. Peripheral Vascular Angiography Contrast Media Market Report

U.S. Peripheral Vascular Angiography Contrast Media Market Report Highlights

• Based on the product, The CT/X-ray segment dominated the market in 2024 and is expected to register a significant CAGR from 2025 to 2030. The rising prevalence of congenital heart diseases (CHDs) significantly increases the demand for CT angiography.

• Based on the modality, Iodinated contrast media dominate the market due to their high efficacy in enhancing the visibility of blood vessels in imaging modalities such as X-ray, CT, and angiography.

• Based on end use, the hospital segment dominated the market in 2024, and it is expected to witness significant growth over the forecast period.

U.S. Peripheral Vascular Angiography Contrast Media Market Segmentation

For this report, Grand View Research has segmented U.S. peripheral vascular angiography contrast media market on the basis of product, modality, and end-use:

U.S. Peripheral Vascular Angiography Contrast Media Product Outlook (Revenue, USD Million; 2018 - 2030)

• CT/X-ray

• Magnetic Resonance Imaging

• Ultrasound

U.S. Peripheral Vascular Angiography Contrast Media Modality Outlook (Revenue, USD Million; 2018 - 2030)

• Iodinated Contrast Media

• Gadolinium-based Contrast Media

• Microbubble

U.S. Peripheral Vascular Angiography Contrast Media End Use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals

• Diagnostic Imaging Centers

• Research Institutes

• Others

List of Key Players in the U.S. Peripheral Vascular Angiography Contrast Media Market

• Guerbet

• Bracco

• Bayer

• GE HealthCare

• Fresenius Kabi USA

• Lantheus Holdings, Inc.